SOPHiA GENETICS (SOPH) Current Deferred Revenue (2020 - 2025)

SOPHiA GENETICS's Current Deferred Revenue history runs 6 years deep, the most recent figure standing at $16.7 million for Q4 2025.

• In Q4 2025, Current Deferred Revenue rose 191.7% year-over-year to $16.7 million; the TTM figure through Dec 2025 stood at $16.7 million (up 191.7% YoY), while the FY2025 annual figure was $16.7 million, up 191.7% from the prior year.
• Current Deferred Revenue came in at $16.7 million for Q4 2025 at SOPHiA GENETICS, up from $10.0 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $16.7 million in Q4 2025 to a low of $3.4 million in Q4 2022.
• A 5-year average of $7.4 million and a median of $7.7 million in 2023 frame the typical range for Current Deferred Revenue.
• Across the five-year window, Current Deferred Revenue tumbled 39.63% in 2024 and jumped 191.7% in 2025, its largest moves.
• SOPHiA GENETICS's Current Deferred Revenue stood at $4.1 million in 2021, then fell by 15.61% to $3.4 million in 2022, then soared by 176.47% to $9.5 million in 2023, then sank by 39.63% to $5.7 million in 2024, then soared by 191.7% to $16.7 million in 2025.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $16.7 million, $10.0 million, and $9.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison